Get the latest tech news
So Much Blood
but how much exactly?
CategoryDescriptionExports ($)Percentage of US goods exports3002.13.00.00IMMUNOLOGICAL PRODUCTS, UNMIXED, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE624,283,1120.0305%3002.14.00.00IMMUNOLOGICAL PRODUCTS, MIXED, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE5,060,866,2080.2475%3002.15.01.00IMMUNOLOGICAL PRODUCTS, PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE13,317,356,4690.6512%3002.41.00.00VACCINES FOR HUMAN MEDICINE, NESOI7,760,695,7440.3795%3002.51.00.00CELL THERAPY PRODUCTS595,963,0100.0291%3002.90.52.50HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLATIC OR DIAGNOSTIC USES; ANTISERA AND OTHER BLOOD FRACTIONS, ETC. When looking at similar data a few years ago, Market Design suggested that that immunoglobulin products might also fall under this category. But I couldn’t find any other source that shows their work in any detail, so I hoped that by publishing this I could at least prod Cunningham’s law into action.
Or read this on Hacker News